iTeos to Present at SVB Securities Global Biopharma
WATERTOWN, Mass. and GOSSELIES, Belgium, Feb. 07, 2023 (GLOBE NEWSWIRE) -- iTeos Therapeutics, Inc. (Nasdaq: ITOS), a
Globe Newswire7-02-2023, 19:05
Ingredion Incorporated Reports Strong 2024 Fourth Quarter and Full-Year Results 4-02-2025, 18:05